Using Nature's strategies in the development of new drugs
Dimerization of the human neuropeptides oxytocin and vasopressin can produce new types of bioactive molecules
2021-02-10
(Press-News.org) Dimerization (Note: combination of two identical or different molecules) of the human neuropeptides oxytocin and vasopressin can produce new types of bioactive molecules. In a recent study, an international research team led by MedUni Vienna and the University of Vienna demonstrated that dimerized and therefore significantly larger versions of oxytocin and vasopressin are still able to activate their receptors. Such new constructs provide several opportunities to optimize the efficacy of these neuropeptides for therapeutic application. The researchers were inspired for this approach from naturally occurring dimers. The results have been published in the journal "Chemical Science".
Oxytocin/vasopressin receptors are typical examples of so-called G protein-coupled receptors - the most successful drug target class. The oxytocin and vasopressin receptors are targeted, for example, during childbirth to encourage contractions but are also being investigated for therapeutic applications in cardiovascular disease, cancer, and developmental disorders such as autism.
Inspired by locusts
MedUni Vienna researchers (led by Christian Gruber from the Institute of Pharmacology), researchers from the University of Vienna (led by Markus Muttenthaler from the Institute of Biological Chemistry of the Faculty of Chemistry) and research partners from Australia and Spain have shown that it is possible to dimerize the human neuropeptides oxytocin and vasopressin without forfeiting too much of their efficacy. The researchers were inspired by a naturally occurring locust neuropeptide, which had the form of a dimer of two vasopressin-like molecules. "By making structural changes to the composition and orientation of the dimers, we managed to modify their pharmacological activity to achieve selective inhibition or activation of the human vasopressin V1a receptor," explains Christian Gruber from MedUni Vienna. Markus Muttenthaler from the University of Vienna adds: "Dimerization is a strategy that is often observed in Nature to optimize stability or mode of action. A good example of this is insulin, which is also a dimer of two different peptides."
600-million-year-old oxytocin-vasopressin signalling system
The researchers use a unique strategy for the discovery of new oxytocin and vasopressin molecules with different pharmacological properties, exploiting the advantages of the evolutionary similarities of the oxytocin-vasopressin signalling system that has been in existence for around 600 million years and is widely distributed in the animal kingdom. These new pharmacological probes provide new insights into receptor function and could also represent new therapeutic leads for several disorders. "Our concept is as innovative as it is fascinating: you take an insect neuropeptide, study its structure and replicate this with minor chemical changes to obtain therapeutic leads for human diseases," explain Gruber and Muttenthaler. "It is equally important to make these new molecules available as research 'tools'. Only by developing receptor-subtype-selective molecules, is it possible to investigate the physiological relevance of these signalling systems," add Gruber and Muttenthaler.
Functions of the oxytocin-vasopressin signalling system studied
The researchers' aim to explain the pharmacological and physiological relevance of this signalling system. "We have studied the function of this signalling system in ants and found that the oxytocin-vasopressin hormone system regulates foraging, physical activity and metabolism." The researchers therefore assume that oxytocin is not merely a 'love hormone' but potentially also acts as an appetite suppressant - an application worth investigating.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-10
In order for a drug to be effective at the right places in the body, it helps if scientists can predict as accurately as possible how the molecules of that drug will interact with human cells. In a joint research project, scientists from Collaborative Research Centre 1423 at Leipzig University and the Chinese Academy of Sciences in Shanghai have succeeded in elucidating such a structure, namely that of the neuropeptide Y receptor Y2 with one of its ligands. This is the first time that a molecular blueprint for this receptor is available, which will enable the development of tailor-made new drugs, for example to treat epilepsy or cardiovascular diseases. The researchers' findings have now been published in Nature Communications.
The Y2 receptor plays ...
2021-02-10
"Insulin is a prime example for a successful peptide drug that has been essential for the health of millions of diabetic patients in the past 100 years," says Markus Muttenthaler, who leads research groups at the Institute of Biological Chemistry of the Faculty of Chemistry at University in Vienna as well as at the Institute for Molecular Bioscience, at the University of Queensland in Brisbane.
Worldwide, peptide therapeutics account for 5% of the global pharmaceutical market, with global sales exceeding US$ 50 billion. More than 150 peptides are in clinical development and another 400-600 peptides undergoing preclinical ...
2021-02-10
Children with epilepsy sleep poorly compared to healthy children, and are more likely to experience disruptions such as night terrors, sleep walking or sleep disordered breathing, according to a new study.
A team at the University of Birmingham's Centre for Human Brain Health analysed 19 published studies on sleep and epilepsy in children and adolescents to try to better understand and articulate the links between them.
Their findings, published in Sleep Medicine Reviews, highlight the significantly poorer sleep experienced by children and adolescents with epilepsy, and present a strong argument for screening children for sleep problems as an integral part of diagnosis and management of the condition.
Lead author Alice Winsor explains: "We know that sleep and epilepsy ...
2021-02-10
Among the most active fields of research in modern physics, both at an academic level and beyond, are quantum computation and communication, which apply quantum phenomena such as superposition and entanglement to perform calculations, or to exchange information. A number of research groups around the world have built quantum devices that are able to perform calculations faster than any classical computer. Yet, there is still a long way to go before these devices can be converted into marketable quantum computers. One reason for this is that both quantum computation and ...
2021-02-10
A new study shows that proteins called IAPs, which can trigger programmed cell death, are inhibited by a specific chemical modification, and reveals that they play a wider role in protein quality control than previously assumed.
N-terminal acetylation - the attachment of an acetyl group (CH3-COO-) directly to the N-terminus of a protein - is one of the most common modifications found in the protein complements of higher organisms. The chemical tag has been linked to a wide variety of cellular signaling pathways. Now researchers led by Tanja Bange (Institute of Medical Psychology, Ludwig-Maximilians-Universitaet (LMU) in Munich) have shown that N-terminal acetylation shields certain proteins from degradation, and inhibits programmed cell death ('apoptosis'). ...
2021-02-10
People who eat a Mediterranean-style diet--particularly one rich in green leafy vegetables and low in meat--are more likely to stay mentally sharp in later life, a study shows.
Closely adhering to a Mediterranean diet was associated with higher scores on a range of memory and thinking tests among adults in their late 70s, the research found.
The study found no link, however, between the Mediterranean-style diet and better brain health.
Markers of healthy brain ageing - such as greater grey or white matter volume, or fewer white matter lesions--did not differ between those regularly eating a Mediterranean diet and those who did not.
These ...
2021-02-10
Washington, DC - February 9, 2021 - A team of investigators from the Republic of China has discovered that 6 drugs previously approved by the US Food and Drug Administration (FDA) for other indications could be repurposed to treat or prevent COVID-19. The research is published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
Using FDA-approved drugs saves time -- the drugs don't need to go through the FDA approval process again -- making them available quickly to treat patients who need them.
The research shows that the investigators screened 2 large drug libraries cumulatively containing 3,769 FDA-approved drugs and found drugs that can inhibit 2 protein-cutting ...
2021-02-10
MOSCOW, Idaho -- Feb. 9, 2021 -- Breastfeeding women with COVID-19 do not pass along the SARS-CoV-2 virus in their milk but do transfer milk-borne antibodies that are able to neutralize the virus, a multi-institutional team of researchers led by the University of Idaho reported.
The team analyzed 37 milk samples submitted by 18 women diagnosed with COVID-19. None of the milk samples were found to contain the virus, but nearly two-thirds of the samples did contain two antibodies specific to the virus.
"Taken together, our data do not support maternal-to-infant transmission of SARS-CoV-2 via milk," the researchers reported ...
2021-02-10
ALBUQUERQUE, N.M. -- Something lurks beneath the Arctic Ocean. While it's not a monster, it has largely remained a mystery.
According to 25 international researchers who collaborated on a first-of-its-kind study, frozen land beneath rising sea levels currently traps 60 billion tons of methane and 560 billion tons of organic carbon. Little is known about the frozen sediment and soil -- called submarine permafrost -- even as it slowly thaws and releases methane and carbon that could have significant impacts on climate.
To put into perspective the amount of greenhouse gases in submarine permafrost, humans have released about 500 billion tons of carbon into the atmosphere since the Industrial Revolution, said Sandia National Laboratories geosciences engineer ...
2021-02-10
The Texas Heart Institute (THI) has announced that a research team led by Dr. Mehdi Razavi, Director of Electrophysiology Clinical Research & Innovations, has developed a breakthrough new ex vivo benchtop system for evaluating the effects of ablation systems on excised tissues and assessing potential damage to collateral heart tissues. The unique system allows for fast and easy benchtop assessments rather than using costly in vivo tests. Critical findings associated with this innovation are outlined in a study published in the Journal of Cardiovascular Physiology.
The new ablation method evaluated by Dr. Razavi and team is being ...
LAST 30 PRESS RELEASES:
[Press-News.org] Using Nature's strategies in the development of new drugs
Dimerization of the human neuropeptides oxytocin and vasopressin can produce new types of bioactive molecules
